NL-OMON49874尚未招募2 期
Sulodexide for chronic heart failure: a proof of concept, randomized, open-label, placebo-controlled study - Sulodexide for chronic heart failure
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Chronic heart failure with reduced ejection fraction (HFrEF)
- •- Elevated NT-proBNP and signs of congestion (e.g. use of diuretics, peripheral
- •- Stable diuretic and antihypertensive treatment
排除标准
- •- Estimated glomerular filtration rate (eGFR) <15 ml/min/1.73m2
- •- Hypotension (systolic < 105 mmHg or diastolic < 60 mmHg)
- •- Anticoagulant therapy or double antiplatelet therapy
- •- Recent cardiovascular event or hospital admission for heart failure
研究者
相似试验
进行中（未招募）
1 期
Sulodexide for chronic heart failureChronic heart failureEUCTR2020-002864-30-NLAmsterdam UMC, location AMC64
已完成
不适用
Thalidomide for chronic heart failureHeart failureCardiovascular: Heart failureCirculatory SystemISRCTN44663253Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)20
招募中
2 期
Glycocalyx restoration in chronic heart failure: a proof of concept, randomized, double-blind, placebo-controlled studyNL-OMON51489Amsterdam UMC64
进行中（未招募）
1 期
Treatment of patients with chronic venous disease of the lower extremities using sulodexideChronic primary venous disease of the lower limbsMedDRA version: 21.1Level: LLTClassification code 10066682Term: Chronic venous insufficiencySystem Organ Class: 100000004866EUCTR2021-002311-64-CZALFASIGMA CZECH s.r.o.290
进行中（未招募）
1 期
Digoxin Evaluation in Chronic heart failure: Investigational Study In Outpatients in the NetherlandsHeart failureEUCTR2018-003789-15-NLDepartment of Cardiology, Hartcentrum, University Medical Center Groningen982